Can a Uterine Polyp Burst? What You Need to Know

Uterine polyps do not burst. They are solid overgrowths of the tissue lining the uterus, not fluid-filled sacs, so there is nothing inside them to rupture or leak. The concern behind this question is usually a real one, though: sudden or heavy vaginal bleeding that feels like something “popped.” That bleeding has a different explanation, and understanding what polyps actually do is more useful than worrying about a scenario that doesn’t happen.

Why a Uterine Polyp Cannot Burst

A uterine polyp (also called an endometrial polyp) is a small, fleshy growth attached to the inner wall of the uterus. It is made of endometrial tissue, the same kind that lines the uterine cavity, along with blood vessels and sometimes glandular elements. Picture a small finger of tissue, sometimes on a stalk, growing inward from the uterine wall. There is no pocket of fluid or gas inside. This makes polyps fundamentally different from ovarian cysts, which are fluid-filled and genuinely can rupture. A polyp is more like a skin tag than a balloon: it can bleed, twist, or become irritated, but it has no internal contents to burst out of.

Endometrial polyps are common and overwhelmingly benign, affecting women of reproductive age and postmenopausal women alike.{1PubMed Central. Endometrial polyps: Pathogenesis, sequelae and treatment} They range from a few millimeters to several centimeters across. Some women have one; others have several. Many polyps produce no symptoms at all and are found incidentally during imaging for other reasons.

What Actually Causes the Sudden Bleeding

When a polyp causes bleeding that feels dramatic or sudden, the mechanism has nothing to do with rupture. Polyps contain blood vessels, and those vessels sit close to the surface of the growth. Several things can trigger noticeable bleeding from a polyp:

  • Surface irritation: The polyp’s surface tissue can erode or become inflamed, especially if it protrudes through the cervix or is physically jostled during intercourse.
  • Hormonal fluctuation: Because polyps are made of endometrial tissue, they respond to estrogen just like the rest of the uterine lining. Hormonal shifts can cause the polyp’s surface to shed or its vessels to dilate, leading to spotting or heavier-than-expected menstrual flow.
  • Twisting of the stalk: Pedunculated polyps (those on a stalk) can twist, partially cutting off their own blood supply. When blood flow returns or the tissue becomes congested, bleeding can follow.

Abnormally heavy menstrual bleeding is one of the most frequently reported symptoms accompanying endometrial polyps.{1PubMed Central. Endometrial polyps: Pathogenesis, sequelae and treatment} Intermenstrual spotting and postmenopausal bleeding are also common presentations. The bleeding can come on suddenly and be alarming, which is probably where the “bursting” idea comes from. But it is the polyp’s blood vessels leaking or its surface shedding, not the polyp itself breaking open.

When Bleeding Warrants Urgent Attention

Most polyp-related bleeding is annoying rather than dangerous. You should seek medical evaluation promptly if you experience postmenopausal bleeding of any amount, heavy bleeding that soaks through a pad or tampon every hour for more than two hours, or bleeding accompanied by dizziness, lightheadedness, or fainting. Postmenopausal bleeding in particular is a finding that doctors take seriously, because it can be caused by conditions other than polyps, including endometrial hyperplasia or cancer.

A polyp itself is unlikely to cause life-threatening hemorrhage. The scenario people fear when they ask whether a polyp can burst, some kind of sudden catastrophic internal bleed, does not happen with endometrial polyps. The more realistic concern is persistent heavy bleeding over time, which can lead to iron-deficiency anemia if left unaddressed.

Are Uterine Polyps Ever Cancerous

The vast majority are benign. In a large pathology review of over a thousand endometrial polyps, about 95% were benign, roughly 1.3% showed precancerous changes (hyperplasia with atypia), and about 1.3% harbored actual endometrial cancer.{2PubMed. Risk and predictors of malignancy in women with endometrial polyps} The risk was not evenly distributed: menopausal status was the strongest predictor. Among premenopausal women, the combined risk of cancer or atypical hyperplasia was around 1% regardless of whether they had bleeding. In postmenopausal women, it rose to about 2% without bleeding and nearly 4% with bleeding.{2PubMed. Risk and predictors of malignancy in women with endometrial polyps}

A separate study focused on postmenopausal women found a higher overall rate of pre-malignancy or malignancy at about 8%, with polyp diameter over 13 millimeters on ultrasound being the strongest predictor.{3PubMed Central. Risk of Pre-Malignancy or Malignancy in Postmenopausal Endometrial Polyps: A CHAID Decision Tree Analysis} Other factors that flagged a higher malignancy risk in research include larger polyp size, greater endometrial thickness, elevated blood sugar, and elevated inflammatory markers.{4PubMed Central. Malignancy risk factors based on endometrial polyp}

None of this means you should panic about a polyp. It does mean that doctors typically recommend removing polyps and sending them for pathology review rather than leaving them indefinitely, especially in postmenopausal women or when a polyp is large. The tissue analysis after removal is the only way to confirm a polyp is truly benign.

How Polyps Are Found

Polyps are often discovered during a transvaginal ultrasound, but a standard ultrasound is not the best tool for confirming them. A meta-analysis comparing imaging methods found that standard transvaginal ultrasound detected polyps with a sensitivity of about 62% and specificity of about 73%, meaning it misses a fair number and sometimes flags things that turn out not to be polyps.{5PubMed Central. Comparison of diagnostic accuracy of saline infusion sonohysterography, transvaginal sonography, and hysteroscopy in evaluating the endometrial polyps in women with abnormal uterine bleeding: a systematic review and meta-analysis}

Saline infusion sonohysterography, where sterile saline is instilled into the uterine cavity during ultrasound to outline its interior, performs much better, with sensitivity and specificity both in the high 80s to low 90s.{6PubMed. Diagnostic accuracy of saline contrast sonohysterography in detecting endometrial polyps in women with postmenopausal bleeding: systematic review and meta-analysis} Hysteroscopy, where a thin camera is inserted through the cervix into the uterus, is the most accurate approach, with sensitivity around 92%.{5PubMed Central. Comparison of diagnostic accuracy of saline infusion sonohysterography, transvaginal sonography, and hysteroscopy in evaluating the endometrial polyps in women with abnormal uterine bleeding: a systematic review and meta-analysis} Hysteroscopy also has the advantage of being diagnostic and therapeutic at the same time: if a polyp is seen during the procedure, it can be removed in the same session.

Polyps Versus Fibroids

People sometimes confuse uterine polyps with fibroids (also called leiomyomas), and this confusion feeds the “bursting” fear because fibroids are larger and sound more intimidating. They are different growths. Polyps arise from the endometrial lining and tend to be soft, while fibroids grow from the muscular wall of the uterus and are denser. On imaging, polyps tend to appear as homogeneous bright masses, while fibroids more often show multiple feeding blood vessels.{7PubMed Central. The sonohysterographic difference in submucosal uterine fibroids and endometrial polyps treated by hysteroscopic surgery} Masses larger than about 2 centimeters are also more likely to be fibroids than polyps.{7PubMed Central. The sonohysterographic difference in submucosal uterine fibroids and endometrial polyps treated by hysteroscopic surgery}

This distinction matters because fibroids and polyps behave differently, require different management strategies, and have different recurrence patterns. A submucosal fibroid (one that pushes into the uterine cavity) can mimic a polyp on a basic ultrasound, which is another reason saline-infusion imaging or hysteroscopy is worth doing when the diagnosis is uncertain.

Treatment and What to Expect from Polypectomy

Hysteroscopic polypectomy is the standard treatment. A thin scope is passed through the cervix, the polyp is visualized directly, and it is removed using small instruments, a loop, or a tissue-removal device. The procedure is typically done as an outpatient, often with local anesthesia or light sedation, and most women go home the same day.{8PubMed Central. Assessment of Long- and Short-Term Outcomes of Hysteroscopic Polypectomy in Patients with Uterine Polyps}

Success rates are high and complication rates are low. Studies comparing different removal techniques, such as mechanical tissue-removal systems versus bipolar loop resection, have found similar long-term outcomes, with no significant differences in recurrence of symptoms or polyps between methods.{9Journal of Endometriosis and Uterine Disorders. Tissue removal system versus bipolar resection for hysteroscopic polypectomy: Long-term results} Recovery is generally quick: mild cramping for a day or two, light spotting for up to a week, and a return to normal activity within a few days. The removed tissue is sent to pathology, which is the part that really matters for ruling out anything concerning.

Do Some Polyps Disappear Without Treatment

Yes, some do. A study following women who were scheduled for surgery but had their procedure delayed found that about 23% of polyps had spontaneously regressed by the time of their re-evaluation.{10PubMed Central. Endometrial polyps: Is the prediction of spontaneous regression possible?} Regression was more common in women under 45, in premenopausal women, and when the polyp was smaller than 2 centimeters.{10PubMed Central. Endometrial polyps: Is the prediction of spontaneous regression possible?}

This is useful context, but it does not mean watchful waiting is always the right approach. The trouble is that you cannot be sure from imaging alone whether a polyp is fully benign or harbors early precancerous changes. Most doctors reserve a watch-and-wait strategy for small, asymptomatic polyps in younger premenopausal women, where both the malignancy risk and the likelihood that the polyp will cause problems are lowest. For postmenopausal women, women with symptoms, or anyone with larger polyps, removal and pathology review is the standard recommendation.

Polyps and Fertility

If you are trying to conceive and have been told you have a uterine polyp, removal is generally recommended regardless of the polyp’s size. Polyps may interfere with embryo implantation by physically occupying space in the uterine cavity or by creating an inflammatory local environment. Research on women undergoing intrauterine insemination found that removing polyps before the procedure more than doubled the clinical pregnancy rate: roughly 63% of women who had the polyp removed became pregnant, compared to about 28% in those who had only a diagnostic look.{11PubMed Central. Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities} Separate research found that this benefit held regardless of how many polyps were present or how large they were.{12PubMed. Pregnancy rates after hysteroscopic polypectomy depending on the size or number of the polyps}

If you are undergoing IVF or other fertility treatments, your reproductive endocrinologist will almost certainly want any polyps cleared out before an embryo transfer. A polyp that is otherwise small and asymptomatic can still meaningfully reduce implantation success.

Recurrence After Removal

Polyps come back more often than people expect. In one study with extended follow-up, 43% of women who had a hysteroscopic polypectomy developed a recurrence.{13PubMed Central. Factors Influencing the Recurrence Potential of Benign Endometrial Polyps after Hysteroscopic Polypectomy} Having multiple polyps at the time of removal and a longer follow-up interval were both associated with higher recurrence risk.{13PubMed Central. Factors Influencing the Recurrence Potential of Benign Endometrial Polyps after Hysteroscopic Polypectomy}

Other recurrence risk factors identified in research include obesity (BMI of 30 or higher), adenomyosis, polycystic ovarian syndrome, the presence of uterine fibroids, and tamoxifen use.{14PubMed Central. Comprehensive Analysis of Risk Factors for Recurrence in Women of Reproductive Age Undergoing Hysteroscopic Polypectomy} Of these, adenomyosis and polycystic ovarian syndrome carried the strongest associations. This means that for some women, polyp removal is not a one-time event but part of an ongoing management plan that includes periodic surveillance with ultrasound or saline-infusion imaging.

The Role of Hormonal Factors

Estrogen plays a central role in polyp formation. Conditions that expose the uterine lining to sustained or excess estrogen, such as obesity, anovulatory cycles in polycystic ovarian syndrome, or hormone therapy, all increase the risk of polyps developing or recurring. Tamoxifen, the breast cancer drug, is a well-known driver of endometrial polyps because while it blocks estrogen’s effects in breast tissue, it acts like estrogen in the uterus.{15PubMed Central. Risk of Endometrial Polyps, Hyperplasia, Carcinoma, and Uterine Cancer After Tamoxifen Treatment in Premenopausal Women With Breast Cancer}

For women taking tamoxifen, one preventive strategy that has shown effectiveness is the levonorgestrel-releasing intrauterine system (a hormonal IUD). A randomized trial with long-term follow-up confirmed that this device prevented endometrial polyps during its period of use in tamoxifen-treated women.{16PubMed. Prevention of tamoxifen induced endometrial polyps using a levonorgestrel releasing intrauterine system long-term follow-up of a randomised control trial} The protective effect lasted only while the device was in place, so it is not a permanent solution, but it is a practical one for women who need to remain on tamoxifen for years.

For women not on tamoxifen, there is no well-proven medication that reliably prevents polyps from forming. Addressing modifiable risk factors like weight management may help reduce recurrence risk given the strong association between obesity and polyp formation, but this has not been tested in a clinical trial specifically designed around polyp prevention.

When You Can Skip Removal Entirely

Not every polyp needs to come out. Small, asymptomatic polyps in premenopausal women younger than 45, with no risk factors for endometrial cancer, are reasonable candidates for surveillance rather than immediate surgery. Given the roughly one-in-four chance of spontaneous regression in this group, a follow-up ultrasound in three to six months to see whether the polyp has grown, stayed the same, or disappeared is a reasonable first step. If the polyp grows, causes symptoms, or the woman reaches menopause, removal becomes the better option.

For postmenopausal women, the calculus shifts. The malignancy risk is higher, spontaneous regression is much less likely, and the consequences of missing a precancerous polyp are more serious. Most gynecologists recommend removal for any polyp found after menopause, even if it is not causing symptoms. The procedure is low-risk, and the peace of mind that comes with a benign pathology report is substantial.